{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:17:10Z","timestamp":1791213430732,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,15]],"date-time":"2020-01-15T00:00:00Z","timestamp":1579046400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,1,15]],"date-time":"2020-01-15T00:00:00Z","timestamp":1579046400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Familial Mediterranean Fever, a monogenic autoinflammatory disease secondary to MEFV gene mutations in the chromosome 16p13, is characterized by recurrent self-limiting attacks of fever, arthritis, aphthous changes in lips and\/or oral mucosa, erythema, serositis. It is caused by dysregulation of the inflammasome, a complex intracellular multiprotein structure, commanding the overproduction of interleukin 1. Familial Mediterranean Fever can be associated with other multifactorial autoinflammatory diseases, as vasculitis and Beh\u00e7et disease.<\/jats:p><jats:p>Symptoms frequently start before 20\u2009years of age and are characterized by a more severe phenotype in patients who begin earlier.<\/jats:p><jats:p>Attacks consist of fever, serositis, arthritis and high levels of inflammatory reactants: C-reactive protein, erythrocyte sedimentation rate, serum amyloid A associated with leucocytosis and neutrophilia. The symptom-free intervals are of different length.<\/jats:p><jats:p>The attacks of Familial Mediterranean Fever can have a trigger, as infections, stress, menses, exposure to cold, fat-rich food, drugs.<\/jats:p><jats:p>The diagnosis needs a clinical definition of the disease and a genetic confirmation. An accurate differential diagnosis is mandatory to exclude infective agents, autoimmune diseases, etc.<\/jats:p><jats:p>In many patients there is no genetic confirmation of the disease; furthermore, some subjects with the relieve of MEFV mutations, show a phenotype not in line with the diagnosis of Familial Mediterranean Fever. For these reasons, diagnostic criteria were developed, as Tel Hashomer Hospital criteria, the \u201cTurkish FMF Paediatric criteria\u201d, the \u201cclinical classification criteria for autoinflammatory periodic fevers\u201d formulated by PRINTO.<\/jats:p><jats:p>The goals of the treatment are: prevention of attacks recurrence, normalization of inflammatory markers, control of subclinical inflammation in attacks-free intervals and prevention of medium and long-term complications, as amyloidosis. Colchicine is the first step in the treatment; biological drugs are effective in non-responder patients.<\/jats:p><jats:p>The goal of this paper is to give a wide and broad review to general paediatricians on Familial Mediterranean Fever, with the relative diagnostic, clinical and therapeutic aspects.<\/jats:p>","DOI":"10.1186\/s13052-019-0766-z","type":"journal-article","created":{"date-parts":[[2020,1,15]],"date-time":"2020-01-15T12:02:37Z","timestamp":1579089757000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["FMF is not always \u201cfever\u201d: from clinical presentation to \u201ctreat to target\u201d"],"prefix":"10.1186","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7777-1239","authenticated-orcid":false,"given":"Maria Cristina","family":"Maggio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Corsello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,15]]},"reference":[{"issue":"1","key":"766_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s10067-014-2721-0","volume":"34","author":"L Cantarini","year":"2015","unstructured":"Cantarini L, Vitale A, Lucherini OM, De Clemente C, Caso F, Costa L, et al. The labyrinth of autoinflammatory disorders: a snapshot on the activity of a third level center in Italy. Clin Rheumatol. 2015;34(1):17\u201328.","journal-title":"Clin Rheumatol"},{"issue":"1","key":"766_CR2","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s13023-017-0720-3","volume":"12","author":"R Papa","year":"2017","unstructured":"Papa R, Doglio M, Lachmann HJ, Ozen S, Frenkel J, Simon A, et al. Paediatric Rheumatology International Trials Organisation (PRINTO) and the Eurofever Project. A web-based collection of genotype-phenotype associations in hereditary recurrent fevers from the Eurofever registry. Orphanet J Rare Dis. 2017;12(1):167. https:\/\/doi.org\/10.1186\/s13023-017-0720-3.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"766_CR3","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s13075-018-1738-1","volume":"20","author":"Y Endo","year":"2018","unstructured":"Endo Y, Koga T, Ishida M, Fujita Y, Tsuji S, Takatani A, et al. Musculoskeletal manifestations occur predominantly in patients with later-onset familial Mediterranean fever: data from a multicenter, prospective national cohort study in Japan. Arthritis Res Ther. 2018;20(1):257. https:\/\/doi.org\/10.1186\/s13075-018-1738-1.","journal-title":"Arthritis Res Ther"},{"key":"766_CR4","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3389\/fped.2018.00377","volume":"6","author":"S Demir","year":"2018","unstructured":"Demir S, Sag E, Dedeoglu F, Ozen S. Vasculitis in Systemic Autoinflammatory Diseases. Front Pediatr. 2018;6:377. https:\/\/doi.org\/10.3389\/fped.2018.00377 eCollection 2018.","journal-title":"Front Pediatr"},{"issue":"1","key":"766_CR5","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00296-018-4123-0","volume":"39","author":"HE S\u00f6nmez","year":"2019","unstructured":"S\u00f6nmez HE, Esmeray P, Batu ED, Ar\u0131c\u0131 ZS, Demir S, Sa\u011f E, \u00d6zen S, Bilginer Y. Is age associated with disease severity and compliance to treatment in children with familial Mediterranean fever? Rheumatol Int. 2019;39(1):83\u20137.","journal-title":"Rheumatol Int"},{"issue":"3","key":"766_CR6","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s10067-019-04452-1","volume":"38","author":"RMK Ekinci","year":"2019","unstructured":"Ekinci RMK, Balc\u0131 S, Akay E, Tumgor G, Dogruel D, Altintas DU, et al. Frequency of functional gastrointestinal disorders in children with familial Mediterranean fever. Clin Rheumatol. 2019 Mar;38(3):921\u20136.","journal-title":"Clin Rheumatol"},{"key":"766_CR7","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s10620-006-3192-1","volume":"51","author":"S Giaglis","year":"2006","unstructured":"Giaglis S, Mimidis K, Papadopoulos V, Thomopoulos K, Sidiropoulos P, Rafail S, et al. Increased frequency of mutations in gene responsible for familial Mediterranean fever (MEFV) in a cohort of patient with ulcerative colitis: evidence for a potential disease-modifying effect? Dig Dis Sci. 2006;51:687\u201392.","journal-title":"Dig Dis Sci"},{"key":"766_CR8","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1097\/00005792-200211000-00001","volume":"81","author":"H Fidder","year":"2002","unstructured":"Fidder H, Chowers Y, Lidar M, Sternberg M, Langevitz P, Livneh A. Crohn\u2019s disease in patients with familial Mediterranean fever. Medicine. 2002;81:411\u20136.","journal-title":"Medicine"},{"issue":"3","key":"766_CR9","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1007\/s11033-010-0326-5","volume":"38","author":"RA Jarjour","year":"2011","unstructured":"Jarjour RA, Dodaki R. Arthritis patterns in familial Mediterranean fever patients and association with M694V mutation. Mol Biol Rep. 2011;38(3):2033\u20136.","journal-title":"Mol Biol Rep"},{"key":"766_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.gene.2017.05.013","volume":"626","author":"N Cekin","year":"2017","unstructured":"Cekin N, Akyurek ME, Pinarbasi E, Ozen F. MEFV mutations and their relation to major clinical symptoms of familial Mediterranean fever. Gene. 2017;626:9\u201313.","journal-title":"Gene"},{"issue":"3","key":"766_CR11","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1097\/MD.0000000000000029","volume":"93","author":"K Migita","year":"2014","unstructured":"Migita K, Agematsu K, Yazaki M, Nonaka F, Nakamura A, Toma T, et al. Familial Mediterranean fever: genotype-phenotype correlations in Japanese patients. Medicine (Baltimore). 2014;93(3):158\u201364.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"766_CR12","doi-asserted-by":"publisher","first-page":"e2019027","DOI":"10.4084\/MJHID.2019.027","volume":"11","author":"R Manna","year":"2019","unstructured":"Manna R, Rigante D. Familial Mediterranean fever: assessing the overall clinical impact and formulating treatment plans. Mediterr J Hematol Infect Dis. 2019;11(1):e2019027. https:\/\/doi.org\/10.4084\/MJHID.2019.027 eCollection 2019.","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"766_CR13","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ijporl.2019.01.042","volume":"119","author":"A Salimov","year":"2019","unstructured":"Salimov A, Akyol U, Cildir B, Batu ED, Ozen S. Evaluation of hearing in pediatric familial Mediterranean fever patients during attack period and attack-free period. Int J Pediatr Otorhinolaryngol. 2019;119:185\u201392. https:\/\/doi.org\/10.1016\/j.ijporl.2019.01.042 Epub 2019 Feb 1.","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"3","key":"766_CR14","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/MEG.0b013e32832b8e10","volume":"23","author":"MC Maggio","year":"2011","unstructured":"Maggio MC, Liotta A, Cardella F, Corsello G. Stevens-Johnson syndrome and cholestatic hepatitis induced by acute Epstein-Barr virus infection. Eur J Gastroenterol Hepatol. 2011;23(3):289.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"766_CR15","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000009547","volume":"97","author":"K Asakura","year":"2018","unstructured":"Asakura K, Yanai S, Nakamura S, Kawaski K, Eizuka M, Ishida K, et al. Familial Mediterranean fever mimicking Crohn disease: A case report. Medicine (Baltimore). 2018 Jan;97(1):e9547. https:\/\/doi.org\/10.1097\/MD.0000000000009547.","journal-title":"Medicine (Baltimore)"},{"key":"766_CR16","doi-asserted-by":"publisher","unstructured":"Sag E, Bilginer Y, Ozen S. Autoinflammatory Diseases with Periodic Fevers. Curr Rheumatol Rep. 19(7):41. https:\/\/doi.org\/10.1007\/s11926-017-0670-8.","DOI":"10.1007\/s11926-017-0670-8"},{"key":"766_CR17","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/0002-9343(67)90167-2","volume":"43","author":"E Sohar","year":"1967","unstructured":"Sohar E, Gafni J, Pras M, Heller H. Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med. 1967;43:227\u201353.","journal-title":"Am J Med"},{"key":"766_CR18","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1093\/rheumatology\/ken509","volume":"48","author":"F Yal\u00e7inkaya","year":"2009","unstructured":"Yal\u00e7inkaya F, Ozen S, Oz\u00e7akar ZB, Aktay N, Cakar N, D\u00fczova A, et al. A new set of criteria for the diagnosis of familial Mediterranean fever in childhood. Rheumatology (Oxford). 2009;48:395\u20138.","journal-title":"Rheumatology (Oxford)"},{"key":"766_CR19","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3899\/jrheum.141249","volume":"43","author":"E Demirkaya","year":"2016","unstructured":"Demirkaya E, Saglam C, Turker T, Kon\u00e9-Paut I, Woo P, Doglio M, et al. Performance of different diagnostic criteria for familial Mediterranean fever in children with periodic fevers: results from a multicenter international registry. J Rheumatol. 2016;43:154\u201360.","journal-title":"J Rheumatol"},{"key":"766_CR20","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1136\/annrheumdis-2014-206580","volume":"74","author":"S Federici","year":"2015","unstructured":"Federici S, Sormani MP, Ozen S, Aktay N, Cakar N, D\u00fczova A, et al. Evidence-based provisional clinical classification criteria for autoinflammatory periodic fevers. Ann Rheum Dis. 2015;74:799\u2013805.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"766_CR21","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1080\/13497413.2018.1481579","volume":"41","author":"K Migita","year":"2018","unstructured":"Migita K, Asano T, Sato S, Koga T, Fujita Y, Kawakami A. Familial Mediterranean fever: overview of pathogenesis, clinical features and management. Immunol Med. 2018 Jun;41(2):55\u201361.","journal-title":"Immunol Med"},{"issue":"4","key":"766_CR22","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1136\/annrheumdis-2015-208690","volume":"75","author":"S Ozen","year":"2016","unstructured":"Ozen S, Demirkaya E, Erer B, Livneh A, Ben-Chetrit E, Giancane G, et al. EULAR recommendations for the management of familial Mediterranean fever. Ann Rheum Dis. 2016;75(4):644\u201351. https:\/\/doi.org\/10.1136\/annrheumdis-2015-208690 Epub 2016 Jan 22.","journal-title":"Ann Rheum Dis"},{"issue":"20","key":"766_CR23","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1056\/NEJMoa1706314","volume":"378","author":"F De Benedetti","year":"2018","unstructured":"De Benedetti F, Gattorno M, Anton J, Ben-Chetrit E, Frenkel J, Hoffman HM, et al. Canakinumab for the treatment of autoinflammatory recurrent fever syndromes. N Engl J Med. 2018;378(20):1908\u201319.","journal-title":"N Engl J Med"},{"issue":"8","key":"766_CR24","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1007\/s10067-018-4119-x","volume":"37","author":"J Sota","year":"2018","unstructured":"Sota J, Vitale A, Insalaco A, Sfriso P, Lopalco G, Emmi G, et al. \u201cWorking group\u201d of systemic autoinflammatory diseases of SIR (Italian Society of Rheumatology). Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study. Clin Rheumatol. 2018;37(8):2233\u201340.","journal-title":"Clin Rheumatol"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-019-0766-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13052-019-0766-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-019-0766-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T00:27:46Z","timestamp":1610584066000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijponline.biomedcentral.com\/articles\/10.1186\/s13052-019-0766-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,15]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["766"],"URL":"https:\/\/doi.org\/10.1186\/s13052-019-0766-z","relation":{},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,15]]},"assertion":[{"value":"3 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"consent for publication was obtained from the parents of the child. The consent is included in the medical records of the patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7"}}